NasdaqGM - Delayed Quote USD

BrainsWay Ltd. (BWAY)

6.44 -0.06 (-0.92%)
At close: June 7 at 4:00 PM EDT
6.31 -0.13 (-2.02%)
After hours: June 7 at 4:14 PM EDT
Loading Chart for BWAY
DELL
  • Previous Close 6.50
  • Open 6.50
  • Bid 6.35 x 100
  • Ask 6.47 x 400
  • Day's Range 6.36 - 6.65
  • 52 Week Range 2.01 - 7.61
  • Volume 25,841
  • Avg. Volume 77,560
  • Market Cap (intraday) 107.321M
  • Beta (5Y Monthly) 0.32
  • PE Ratio (TTM) --
  • EPS (TTM) -0.11
  • Earnings Date Aug 7, 2024 - Aug 12, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 11.35

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

www.brainsway.com

134

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BWAY

Performance Overview: BWAY

Trailing total returns as of 6/9/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BWAY
0.62%
TA-125
3.99%

1-Year Return

BWAY
191.93%
TA-125
8.58%

3-Year Return

BWAY
44.00%
TA-125
11.03%

5-Year Return

BWAY
33.46%
TA-125
36.36%

Compare To: BWAY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BWAY

Valuation Measures

Annual
As of 6/7/2024
  • Market Cap

    113.69M

  • Enterprise Value

    68.17M

  • Trailing P/E

    --

  • Forward P/E

    322.58

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.13

  • Price/Book (mrq)

    2.56

  • Enterprise Value/Revenue

    1.99

  • Enterprise Value/EBITDA

    177.53

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.83%

  • Return on Assets (ttm)

    -1.18%

  • Return on Equity (ttm)

    -3.90%

  • Revenue (ttm)

    34.26M

  • Net Income Avi to Common (ttm)

    -1.66M

  • Diluted EPS (ttm)

    -0.11

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    47.58M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    3.09M

Research Analysis: BWAY

Company Insights: BWAY

Research Reports: BWAY

People Also Watch